How Abuse-Deterrent Reformulated Opioids Can Stop a Costly Problem: Diversion

How Abuse-Deterrent Reformulated Opioids Can Stop a Costly Problem: Diversion

In this presentation, Dan Cohen, Executive Vice President, Government & Public Relations, presents on:

  • Why you should invest in ADFs and the investments made so far
  • Understanding how ADFs are effective in reducing the diversion of pharmaceutical products
  • Comparing recent data on drug abuse and diversion before and after formulation
  • Learning from law enforcement to round out your pharmaceutical landscape


Please note: That all fields marked with an asterisk (*) are required.